Latest / Lung Cancer Considered
ESMO 2026 Highlights – Part 2
In Part 2 of our ESMO 2026 Highlights series, Dr. Stephen Liu and Dr. Narjust Florez welcome Dr. Xiao-Rong Dong, Dr. Yi-Long Wu, and Dr. Chantal Decroisette to discuss three important clinical trials: SAFFRON, SANOVO, and PERSEE. The conversations explore emerging strategies for targeting MET in EGFR-mutated non-small cell lung cancer, advances in first-line immunotherapy, and the potential implications of these findings for clinical practice. Xiao-Rong Dong, MD, PhD (xiaorongdong@hust.edu.cn) Professor, Chief Physician and Doctoral Supervisor Director, Department of Thoracic Oncology Cancer…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.